Amphetamine-positive urine drug screens in the setting of mexiletine use: A case series.
Division of Internal Medicine, University of California at San Diego, San Diego, California.
Quan M
QM
Bui
Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado.
Larry A
LA
Allen
Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, Colorado.
Andrew A
AA
Monte
University of Colorado Skaggs School of Pharmacy, Aurora, Colorado.
Robert L
RL
Page
Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado.
Colleen K
CK
McIlvennan
D000328:Adult; D000368:Aged; D000661:Amphetamine / Q000652:urine*; D015415:Biomarkers / Q000652:urine; D000697:Central Nervous System Stimulants / Q000652:urine; D002849:Chromatography, Gas; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D006333:Heart Failure / Q000628:therapy*; D016027:Heart Transplantation; D006801:Humans; D021621:Imaging, Three-Dimensional; D008297:Male; D008801:Mexiletine / Q000494:pharmacology*; D008875:Middle Aged; D015203:Reproducibility of Results; D015813:Substance Abuse Detection / Q000379:methods*; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000652:urine; D014057:Tomography, X-Ray Computed; D061567:Voltage-Gated Sodium Channel Blockers / Q000494:pharmacology
D015415:Biomarkers; D000697:Central Nervous System Stimulants; D061567:Voltage-Gated Sodium Channel Blockers; D008801:Mexiletine; D000661:Amphetamine